Anders Erik Astrup Dahm

Bilde av Anders Erik Astrup Dahm
English version of this page
Brukernavn
Besøksadresse Sykehusveien 25 1474 NORDBYHAGEN
Postadresse Akershus universitetssykehus 1478 LØRENSKOG

Publikasjoner

  • Prebensen, Christian; Trøseid, Marius; Ueland, Thor; Dahm, Anders Erik A; Sandset, Per Morten; Aaberge, Ingeborg Sundsvalen; Waalen, Kristian; Dyrhol-Riise, Anne Ma; Tasken, Kjetil & Kvale, Dag (2017). Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial . PLoS ONE.  ISSN 1932-6203.  12:e0176527(5), s 1- 20 . doi: 10.1371/journal.pone.0176527 Fulltekst i vitenarkiv
  • Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders Erik A; Iversen, Nina; Sandset, Per Morten & Skretting, Grethe (2016). Oestrogens downregulate tissue factor pathway inhibitor through oestrogen response elements in the 5′-flanking region. PLoS ONE.  ISSN 1932-6203.  11(3) . doi: 10.1371/journal.pone.0152114
  • Cui, Xue-Yan; Tinholt, Mari; Stavik, Benedicte; Dahm, Anders Erik A; Kanse, Sandip; Jin, Yang; Seidl, Sebastian; Sahlberg, Kristine Kleivi; Iversen, Nina; Skretting, Grethe & Sandset, Per Morten (2016). Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  14(2), s 387- 396 . doi: 10.1111/jth.13206
  • Johnson, Karen C; Aragaki, Aaron; Jackson, Rebecca; Reiner, Alex P; Sandset, Per Morten; Rosing, Jan; Dahm, Anders Erik A; Rosendaal, Frits; Manson, JoAnn E; Martin, Lisa W; Liu, Simin; Kuller, Lewis H; Cushman, Mary & Rossouw, Jacques E (2016). Tissue factor pathway inhibitor, activated protein C resistance, and risk of coronary heart disease due to combined estrogen plus progestin therapy. Arteriosclerosis, Thrombosis and Vascular Biology.  ISSN 1079-5642.  36(2), s 418- 424 . doi: 10.1161/ATVBAHA.115.306905
  • Iversen, Per Ole; Dahm, Anders Erik A; Skretting, Grethe; Mowinckel, Marie-Christine; Haslestad, Annicke Stranda; Østerud, Bjarne; Sandset, Per Morten & Kostovski, Emil (2015). Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study.. Thrombosis and Haemostasis.  ISSN 0340-6245.  114(5), s 964- 968 . doi: 10.1160/TH15-05-0396
  • Kostovski, Emil; Dahm, Anders Erik A; Mowinckel, Marie-Christine; Stranda, Annicke; Skretting, Grethe; Østerud, Bjarne; Sandset, Per Morten & Iversen, Per Ole (2015). Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin. Spinal Cord.  ISSN 1362-4393.  53, s 285- 290 . doi: 10.1038/sc.2014.243
  • Stiksrud, Birgitte; Nowak, Piotr; Nwosu, Felix Chinweije; Kvale, Dag; Thalme, Anders; Sönnerborg, Anders; Ueland, Per Magne; Holm, Kristian; Birkeland, Stein-Erik; Dahm, Anders Erik A; Sandset, Per Morten; Rudi, Knut; Hov, Johannes Espolin Roksund; Dyrhol-Riise, Anne Ma & Trøseid, Marius (2015). Reduced levels of D-dimer and changes in gut microbiota composition after probiotic intervention in HIV-infected individuals on stable ART. Journal of Acquired Immune Deficiency Syndromes.  ISSN 1525-4135.  70(4), s 329- 337 . doi: 10.1097/QAI.0000000000000784
  • Kristiansen, Annette; Brandt, Linn; Agoritsas, Thomas; Akl, Elie A.; Berge, Eivind; Bondi, Johan Fridtjof; Dahm, Anders Erik A; Granan, Lars-Petter; Halvorsen, Sigrun; Holme, Pål Andre; Jacobsen, Anne Flem; Jacobsen, Eva-Marie; Neumann, Ignacio; Sandset, Per Morten; Sætre, Torunn; Tveit, Arnljot; Vartdal, Trond; Guyatt, Gordon & Vandvik, Per Olav (2014). Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process . Chest.  ISSN 0012-3692.  146(3), s 727- 734 . doi: 10.1378/chest.13-2828
  • Tinholt, Mari; Viken, Marte K; Dahm, Anders Erik A; Vollan, Hans Kristian Moen; Sahlberg, Kristine Kleivi; Garred, Øystein; Børresen-Dale, Anne-Lise; Jacobsen, Anne Flem; Kristensen, Vessela N.; Bukholm, Ida Rashida Khan; Kåresen, Rolf; Schlichting, Ellen; Skretting, Grethe; Lie, Benedicte Alexandra; Sandset, Per Morten & Iversen, Nina (2014). Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study. BMC Cancer.  ISSN 1471-2407.  14 . doi: 10.1186/1471-2407-14-845
  • Vartdal, Trond; Fetveit, Arne; Kristiansen, Annette; Brandt, Linn; Halvorsen, Sigrun; Berge, Eivind; Dahm, Anders Erik A; Sandset, Per Morten & Vandvik, Per Olav (2014). Antitrombotisk behandling og profylakse: - ny generasjon retningslinjer for allmennleger . Utposten.  ISSN 0800-5680.  3, s 41- 43
  • Raps, M; Helmerhorst, FM; Fleischer, K; Dahm, Anders Erik A; Rosendaal, FR; Rosing, J; Reitsma, P; Sandset, Per Morten & van Vliet, HAAM (2013). The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Thrombosis and Haemostasis.  ISSN 0340-6245.  109(4), s 606- 613 . doi: 10.1160/TH12-10-0771
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2012). Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism A population-based case-control study. Thrombosis and Haemostasis.  ISSN 0340-6245.  108(6), s 1165- 1171 . doi: 10.1160/TH12-05-0350
  • Dahm, Anders Erik A; Bezemer, Irene D; Bergrem, Astrid; Jacobsen, Anne Flem; Jacobsen, Eva-Marie; Skretting, Grethe; Rosendaal, Frits Richard & Sandset, Per Morten (2012). Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis. British Journal of Haematology.  ISSN 0007-1048.  157(6), s 753- 761 . doi: 10.1111/j.1365-2141.2012.09121.x
  • Dahm, Anders Erik A; Eilertsen, Anette Løken; Goeman, Jelle; Olstad, Ole Kristoffer; Øvstebø, Reidun; Kierulf, Peter; Mowinckel, Marie-Christine; Skretting, Grethe & Sandset, Per Morten (2012). A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thrombosis Research.  ISSN 0049-3848.  130(1), s 45- 51 . doi: 10.1016/j.thromres.2011.12.009
  • Skretting, Grethe; Iversen, Nina; Myklebust, Christiane Filion; Dahm, Anders Erik A & Sandset, Per Morten (2012). Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-kappa B and apoptosis mediated by a caspase-3 independent pathway. Molecular Biology Reports.  ISSN 0301-4851.  39(12), s 10089- 10096 . doi: 10.1007/s11033-012-1882-7
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Mowinckel, Marie-Christine; Sandvik, Leiv & Sandset, Per Morten (2011). Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism. British Journal of Haematology.  ISSN 0007-1048.  154(2), s 241- 247 . doi: 10.1111/j.1365-2141.2011.08712.x
  • Kostovski, Emil; Dahm, Anders Erik A; Iversen, Nina; Hjeltnes, Nils; Østerud, Bjarne; Sandset, Per Morten & Iversen, Per Ole (2011). Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagulation and Fibrinolysis.  ISSN 0957-5235.  22(4), s 254- 259 . doi: 10.1097/MBC.0b013e3283442ce2
  • Pettersen, Frank Olav; Torheim, Eirik A.; Dahm, Anders Erik A; Aaberge, Ingeborg Sundsvalen; Lind, Andreas; Holm, Malin; Aandahl, Einar Martin; Sandset, Per Morten; Tasken, Kjetil & Kvale, Dag (2011). An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: Downregulated immune activation and improved T Cell-dependent vaccine responses. Journal of Virology.  ISSN 0022-538X.  85(13), s 6557- 6566 . doi: 10.1128/JVI.00073-11
  • Jacobsen, Anne Flem; Dahm, Anders Erik A; Bergrem, Astrid; Jacobsen, Eva-Marie & Sandset, Per Morten (2010). Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  8(11), s 2443- 2449 . doi: 10.1111/j.1538-7836.2010.04038.x
  • Sandset, Per Morten; Høibraaten, Else; Eilertsen, Anette Løken & Dahm, Anders Erik A (2009). Mechanisms of thrombosis related to hormone therapy. Thrombosis Research.  ISSN 0049-3848.  123, s S70- S73 . doi: doi:10.1016/S0049-3848(09)70015-5
  • van Vliet, Huib AAM; Bertina, Rogier M; Dahm, Anders Erik A; Rosendaal, Frits; Rosing, Jan; Sandset, Per Morten & Helmerhorst, FM (2008). Different effects of oral contraceptives containing different progestogens on protein S and Tissue Factor Pathway Inhibitor. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  6(2), s 346- 351 . doi: 10.1111/j.1538-7836.2007.02863.x
  • Dahm, Anders Erik A; Iversen, Nina; Birkenes, Bård; Ree, Anne Hansen & Sandset, Per Morten (2006). Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovascular Disorders.  ISSN 1471-2261.  6 . doi: doi:10.1186/1471-2261-6-40
  • Dahm, Anders Erik A; Iversen, Per Ole; Hjeltnes, Nils & Sandset, Per Morten (2006). Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured. Thrombosis Research.  ISSN 0049-3848.  118(2), s 281- 287
  • Dahm, Anders Erik A; Osterud, B; Hjeltnes, N; Sandset, PM & Iversen, Per Ole (2006). Opposite circadian rythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  4(8), s 1840- 1842
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2005). A novel anticoagulant activity assay of tissue factor pathway inhibitor 1 (TFPI). Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  3, s 651- 658
  • Iversen, Per Ole; Dahm, Anders Erik A & Sandset, Per Morten (2005). Circadian variations within the hemostatic and fibrinolytic systems with emphasis on venous thromboembolism, In Frank Columbus (ed.),  Trends in Chronobiology Research.  Nova Science Publishers, Inc..  ISBN 1-59454-482-4.  Chapter 12.  s 281 - 297
  • Negaard, Helene; Dahm, Anders Erik A; Sandset, Per Morten; Østenstad, Bjørn & Iversen, Per Ole (2005). Angiogenesis and hemostasis in hematological neoplasias. Current Drug Targets.  ISSN 1389-4501.  6, s 683- 699
  • Visser, MC; Hylckama Vlieg, Astrid; Tans, Guido; Rosing, Jan; Dahm, Anders Erik A; Sandset, Per Morten; Rosendaal, Frits & Bertina, Rogier M (2005). Determinants of the APTT- and ETP-based APC sensitivity tests. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  3(7), s 1488- 1494
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2003). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood.  ISSN 0006-4971.  101(11), s 4387- 4392
  • Dahm, Anders Erik A & Brørs, Odd (2002). Phenytoin toxicity caused by interaction with ticlopidin. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  37, s 4- 9
  • Blomhoff, Svein; Jacobsen, M.B.; Spetalen, S.; Dahm, Anders Erik A & Malt, Ulrik Fredrik (2000). Perceptual hyperreactivity to auditory stimuli in patients with Irritabel Bowel Syndrome. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  35, s 583- 589

Se alle arbeider i Cristin

  • Dahm, Anders Erik A & Ghanima, Waleed Khalid (2017). Nye direktevirkende antikoagulasjonsmidler til kreftpasienter?. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  137(3), s 171- 172 . doi: 10.4045/tidsskr.17.0008
  • Utne, Kristin Kornelia; Wik, Hilde Skuterud; Jelsness-Jørgensen, Lars-Petter; Sandset, Per Morten; Dahm, Anders Erik A; Tavoly, Mazdak & Ghanima, Waleed Khalid (2017). Rivaroxaban Reduces the Rate of Post-Thrombotic Syndrome After DVT - a Cross-Sectional Study Comparing Rivaroxaban to Warfarin.
  • Dahm, Anders Erik A; Tiscia, Gianluca; Holmgren, Asbjørn; Jacobsen, Anne Flem; Skretting, Grethe; Grandone, E. & Sandset, Per Morten (2015). Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  13(3), s 409- 413 . doi: 10.1111/jth.12817
  • Jacobsen, Eva-Marie; Dahm, Anders Erik A; Vartdal, Trond & Sandset, Per Morten (2014). Antikoagulasjon ved venøs trombose og indremedisinsk sykdom. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  134(9), s 924- 924
  • Kristiansen, Annette; Brandt, Linn; Berge, Eivind; Dahm, Anders Erik A; Halvorsen, Sigrun; Sandset, Per Morten & Vandvik, Per Olav (2014). Nye retningslinjer for antitrombotisk behandling og tromboseprofylakse. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  134(9), s 921- 922 . doi: 10.4045/tidsskr.13.1582
  • Stiksrud, Birgitte; Nowak, Piotr; Kvale, Dag; Thalme, Anders; Birkeland, Stein-Erik; Dahm, Anders Erik A; Dyrhol-Riise, Anne Ma & Trøseid, Marius (2014). Reduced D-dimer levels and inflammation markers after probiotic supplement in HIV-infected on ART.
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2013). Differential risk factors for pregnancy-related deep vein thrombosis and pulmonary embolism - Results from a population-based case-control study. Thrombosis Research.  ISSN 0049-3848.  131, s S75- S75
  • Tinholt, Mari; Viken, MK; Borresen-Dale, AL; Kristensen, V; Karesen, R; Schlichting, E; Oystein, G; Lie, Benedicte Alexandra; Dahm, Anders Erik A; Skretting, Grethe; Sandset, Per Morten & Iversen, Nina (2013). The link between the hemostatic system and cancer: A genotype-phenotype study in breast cancer patients. Thrombosis Research.  ISSN 0049-3848.  131, s S75- S76
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Sandvik, Leiv & Sandset, Per Morten (2012). Differential risk factors for pregnancy related deep vein thrombosis and pulmonary embolism' results from a population-based case-control study. Thrombosis Research.  ISSN 0049-3848.  130, s S122- S123 . doi: 10.1016/j.thromres.2012.08.059
  • Skretting, Grethe; Iversen, Nina; Myklebust, Christiane Filion; Dahm, Anders Erik A & Sandset, Per Morten (2012). Apoptosis in CHO-K1 cells overexpressing TFPI involves both intrinsic and extrinsic pathways additional to induced activation of NF-kappa B. Thrombosis Research.  ISSN 0049-3848.  129, s S192- S192
  • Bergrem, Astrid; Dahm, Anders Erik A; Jacobsen, Anne Flem; Mowinckel, Marie-Christine; Sandvik, Leiv & Sandset, Per Morten (2011). Reduced sensitivity to activated protein C in the absence of the factor V Leiden polymorphism is a risk factor for pregnancy related venous thrombosis. Thrombosis Research.  ISSN 0049-3848.  127, s S127- S127
  • Dahm, Anders Erik A; Eilertsen, Anette Løken; Goeman, J.; Olstad, Ole Kristoffer; Øvstebø, Reidun; Kierulf, Peter; Mowinckel, Marie-Christine; Skretting, Grethe & Sandset, Per Morten (2011). A microarray study on the effect of four hormone therapy regimens on gene transcription in leucocytes from healthy postmenopausal women. Thrombosis Research.  ISSN 0049-3848.  127, s S124- S124
  • Dahm, Anders Erik A; Bezemer, ID; Sandset, Per Morten & Rosendaal, Frits (2010). Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  8(5), s 1130- 1132 . doi: 10.1111/j.1538-7836.2010.03805.x
  • Dahm, Anders Erik A; Bezemer, Irene D; Bergrem, Astrid; Jacobsen, Anne Flem; Jacobsen, Eva-Marie; Skretting, Grethe; Rosendaal, Frits & Sandset, Per Morten (2010). Candidate Gene Polymorphisms and the Risk for Pregnancy Related Venous Thrombosis. Blood.  ISSN 0006-4971.  116(21), s 1708- 1709
  • Dahm, Anders Erik A; Sandset, Per Morten & Rosendaal, Frits (2008). The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1. Journal of Thrombosis and Haemostasis.  ISSN 1538-7933.  6, s 393- 395 . doi: 10.1111/j.1538-7836.2007.02859.x
  • Negaard, Helene FS; Eilertsen, Anette Løken; Dahm, Anders Erik A; Iversen, Per Ole; Østenstad, Bjørn & Sandset, Per Morten (2006). Decreased lung cancer survival with hormone replacement therapy – Due to decreased tissue factor pathway inhibitor level?. Journal of Clinical Oncology.  ISSN 0732-183X.  24(17), s 2683- 2684
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). A novel assay for tissue factor pathway inhibitor (TFPI) anticoagulant activity in plasma.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). A novel assay for tissue factor pathway inhibitor (TFPI) anticoagulant activity in plasma.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits & Sandset, Per Morten (2004). Biological relevance of a new TFPÌ anticoagulant activity assay of full-length TFPI.
  • Dahm, Anders Erik A; Høibraaten, Else; Morrissey, Jim; Andersen, Trine Opstad & Sandset, Per Morten (2004). The influence of hormone replacement therapy (HRT) on the factor VIIa/antithrombin (FVIIa/AT) complex.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A; Andersen, Trine Opstad; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Tissue factor pathway inhibitor (TFPI) and the risk of deep venous thrombosis (DVT).
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
  • Dahm, Anders Erik A; Vlieg, Astrid van Hylckama; Bendz, Bjørn; Rosendaal, Frits; Bertina, Rogier M. & Sandset, Per Morten (2002). Tissue factor pathway inhibitor (TFPI) and risk of deep venous thrombosis (DVT).

Se alle arbeider i Cristin

Publisert 6. mars 2014 12:30 - Sist endret 1. juni 2016 08:52